Published in

Springer, Clinical Rheumatology, 9(39), p. 2563-2572, 2020

DOI: 10.1007/s10067-020-05015-5

Links

Tools

Export citation

Search in Google Scholar

Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO